About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
Net sales grew +12% (cc 1, +11% USD) with core operating income 1 up +22% (cc, +19% USD) Sales growth driven by continued st ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
Novartis is reimagining medicine to improve and extend people’s lives. We provide financial support for educational, advocacy and outreach activities that help advance our goals of improving patient ...
Mehr als 70.000 Mitarbeitende setzen sich bei Novartis weltweit gemeinsam dafür ein, das Leben von Patient*innen zu verlängern und zu verbessern. Willst du dabei sein? Dann denke mit uns Medizin und ...
Bekijk hieronder de opportuniteiten bij Novartis. Voor functies bij Novartis Gene Therapies (voorheen AveXis), ga naar GTx Career Search.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback